2014Journal of Shandong UniversityRequires access

Comparison of the effects between escitalopram and venlafaxine on the social function in patients with depression

Qi Li

Open publisher page 0 citations

Abstract

Objective To compare the effects of escitalopram and venlafaxine on the social function in patients with depression. Methods A total of 100 patients who met the diagnostic criteria of depression were randomly divided into two groups and treated with escitalopram and venlafaxine respectively. The therapeutic efficacy was measured with Hamilton depression scale(HAM D-17); the improvement of social function was measured with Sheehan disability scale(SDS) and the short form-36 health survey(SF-36). The side effects were evaluated by the treatment emergent symptom scale(TESS). Results There were no significant differences in the HAM D scores between the two groups at each interviewtime(P 0. 05),but the scores of HAM D in both groups decreased significantly compared with the baseline(P 0. 01). There were no significant differences in the effective rate and remission rate after 8 weeks of treatment between the two groups(P 0. 05). There were marked differences in scores of SDS and social functions factor scores of SF-36 at the end of the 8th week and the baseline in both groups(P 0. 01),but no significant differences before treatment and after 8 weeks of therapy(P 0. 05). Conclusion Both escitalopram and venlafaxine can effectively improve the social function in patients with depression,with no statistically significant differences between them.

About this research paper

What this paper is about

Objective To compare the effects of escitalopram and venlafaxine on the social function in patients with depression. Methods A total of 100 patients who met the diagnostic criteria of depression were randomly divided into two groups and treated with escitalopram and venlafaxine respectively. The therapeutic efficacy was measured with Hamilton depression scale(HAM D-17); the improvement of social function was measured with Sheehan disability scale(SDS) and the short form-36 health survey(SF-36). The side effects were evaluated by the treatment emergent symptom scale(TESS). Results There were no significant differences in the HAM D scores between the two groups at each interviewtime(P 0. 05),but the scores of HAM D in both groups decreased significantly compared with the baseline(P 0. 01). There were no significant differences in the effective rate and remission rate after 8 weeks of treatment between the two groups(P 0. 05). There were marked differences in scores of SDS and social functions factor scores of SF-36 at the end of the 8th week and the baseline in both groups(P 0. 01),but no significant differences before treatment and after 8 weeks of therapy(P 0. 05). Conclusion Both escitalopram and venlafaxine can effectively improve the social function in patients with depression,with no statistically significant differences between them.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the effects of escitalopram and venlafaxine on the social function in patients with depression. Methods A total of 100 patients who met the diagnostic criteria of depression were randomly divided into two groups and treated with escitalopram and venlafaxine respectively. The therapeutic efficacy was measured with Hamilton depression scale(HAM D-17); the improvement of social function was measured with Sheehan disability scale(SDS) and the short form-36 health survey(SF-36). The side effects were evaluated by the treatment emergent symptom scale(TESS). Results There were no significant differences in the HAM D scores between the two groups at each interviewtime(P 0. 05),but the scores of HAM D in both groups decreased significantly compared with the baseline(P 0. 01). There were no significant differences in the effective rate and remission rate after 8 weeks of treatment between the two groups(P 0. 05). There were marked differences in scores of SDS and social functions factor scores of SF-36 at the end of the 8th week and the baseline in both groups(P 0. 01),but no significant differences before treatment and after 8 weeks of therapy(P 0. 05). Conclusion Both escitalopram and venlafaxine can effectively improve the social function in patients with depression,with no statistically significant differences between them.

Key concepts: Escitalopram, Venlafaxine, Depression (economics), Internal medicine, Hamilton depression scale, Citalopram, Psychology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of the effects between escitalopram and venlafaxine on the social function in patients with depression — Research Paper | ScholarLens